
Michel Georges Khouri MD
Echocardiography, Heart Failure & Transplantation
Associate Professor of Medicine-Cardiology, Duke University School of Medicine
Join to View Full Profile
40 Duke Medicine CirDurham, NC 27710
Phone+1 919-681-1300
Dr. Khouri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 2008 - 2012
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2004 - 2008
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2004
Certifications & Licensure
- NC State Medical License 2008 - 2026
- TX State Medical License 2007 - 2013
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
- American Society of EchocardiographyEchocardiography
Publications & Presentations
PubMed
- Returning Individual-Level Urgent or Emergent Research Results to Participants: The Project Baseline Health Study Experience.Neha Pagidipati, Brooke Heidenfelder, Lydia Coulter Kwee, Fatima Rodriguez, Ranee Chatterjee
American Journal of Medicine Open. 2025-06-01 - Atypical Presentation of an Increasingly Recognized Disease: Transthyretin Amyloidosis Presenting With 18F-Fluorodeoxyglucose Uptake on Cardiac Positron Emission Tomog...Kyla Brezitski, Karen Flores Rosario, Han W Kim, Johana R Fajardo, Michel G Khouri
Circulation. Heart Failure. 2025-04-02 - Hospital-Level Variation and Predictive Model for Diagnosis of Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized for Heart Failure.Satoshi Shoji, Nicole Solomon, Karen Chiswell, Senthil Selvaraj, Michel G Khouri
Journal of Cardiac Failure. 2025-03-26
Press Mentions
- Duke Heart Pulse — February 23, 2025February 23rd, 2025
- BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA MeetingMay 25th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: